AIDS 2024 Conference: ANRS MIE presence
The 25th International AIDS Conference, organized by the International AIDS Society and with financial support from ANRS Emerging Infectious Diseases, will be held from July 22 to 26, 2024 in Munich, Germany. The conference can also be attended online by registering.
From 22 to 26 July 2024
The essential
This event is an opportunity for French research to review its progress and exchange views with international actors in the field of HIV. Find out more about the ANRS MIE’s presence at the AIDS 2024 conference and the projects supported by the ANRS MIE and selected for this 25th edition.
Satellite at AIDS 2024: “Immune control of viral reservoirs” by ANRS MIE , RHIVIERA and DZIF HIV
The satellite will take place at the AIDS 2024 conference in Munich on July 25, 2024 from 6pm to 7:30pm in room 5. It can also be attended online on channel 8. Find the satellite symposium in the AIDS 2024 program.
This symposium is co-organized by the RHIVIERA consortium (Remission of HIV Infection ERA) of the ANRS MIE . The RHIVIERA consortium aims to explore and develop new strategies for reaching durable remission of HIV infection, so that people living with HIV can discontinue antiretroviral treatment sustainably without experiencing viral rebound.
Satellite presentation
The complete elimination of infected cells (HIV cure) is challenging, even with aggressive strategies such as hematopoietic stem cell transplantation. On the other hand, the immune responses developed against HIV during natural infection present early alterations that ART cannot fully reverse, impairing the efficient immune control of infection upon ART interruption. Therefore, new targeted immunotherapies are among the priorities for HIV remission/cure approaches. Studies including extraordinary individuals who control HIV infection for decades in the absence of ART (natural and post-treatment controllers) and in the natural hosts of SIV have provided unique insights into immune responses associated with durable viral control. These immune responses are thus optimal models to guide the development of efficient HIV immunotherapies. This satellite will discuss the study of such immune correlates of control and the development of novel immunotherapies for achieving HIV remission.
Satellite program at AIDS 2024
| 18:00 |
Welcome – Yazdan Yazdanpanah, ANRS, France
|
|
| 18:05 | Immunotherapies in people treated during acute HIV infection, Thumbi Ndung u, Africa Health Research Institute (AHRI), South Africa | |
| 18:17 | HIV-1 broadly neutralizing antibodies and their potential role in future cure strategies, Philipp Schommers, Cologne University Hospital, Germany | |
| 18:29 | MHC-E presentation of SIV-derived peptides mediated antigen-specific NK cell responses in SIV-infected rhesus macaques,Philippe Rascle, Duke University, United States | |
| 18:41 |
Characterization of the HIV/SIV reservoir in viral control models – French cohort studies, Véronique Avettand-Fenoel, CHU Orléans, France
|
|
| 18:53 | Teaching an old dog a new trick: how to harness the immune system to control HIV, Mirko Paiardini, Etats-Unis | |
| 19:05 |
Q&A
Michaela Muller-Trutwin, Institut Pasteur, France
Véronique Avettand-Fenoel, CHU Orléans, France
Mirko Paiardini, United States
|